During the past decade, Skånes Universitetssjukhus Malmö; Reumatologkliniken conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Skånes Universitetssjukhus Malmö; Reumatologkliniken" are "Rheumatoid Arthritis" (3 trials), "Giant Cell Arteritis" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Skånes Universitetssjukhus Malmö; Reumatologkliniken" in a lesser frequency.

Most popular intervention types in "Skånes Universitetssjukhus Malmö; Reumatologkliniken" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (2 trials), "Tocilizumab" (2 trials), "Adalimumab" (1 trials), "Baricitinib" (1 trials) and "Corticosteroids" (1 trials). Other intervention names were less common.

The vast majority of trials in "Skånes Universitetssjukhus Malmö; Reumatologkliniken" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Skånes Universitetssjukhus Malmö; Reumatologkliniken". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Skånes Universitetssjukhus Malmö; Reumatologkliniken, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Skånes Universitetssjukhus Malmö; Reumatologkliniken, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".